This study reports the use of the recently developed EASZY assay that uses transgenic cyp19a1b-GFP zebrafish (Danio rerio) embryos to assess in vivo estrogenic activity of 33 surface (SW) and waste water (WW) samples collected across Europe that were previously well-characterized for estrogen hormones and in vitro estrogenic activity. We showed that 18 out of the 33 SW and WW samples induced estrogenic responses in the EASZY assay leading to a significant and concentration-dependent up-regulation of the ER-regulated cyp19a1b gene expression in the developing brain. The in vivo 17β-estradiol-equivalents (EEQs) were highly correlated with, both, the chemical analytical risk quotient (RQ) based on steroidal estrogen concentrations and EEQs reported from five different in vitro reporter gene assays. Regression analyses between the vitro and in vivo effect concentrations allowed us to determine an optimal cut-off value for each in vitro assay, above which in vivo responses were observed. These in vitro assay-specific effect-based trigger values (EBTs), ranging from 0.28 to 0.58 ng EEQ/L define the sensitivity and specificity of the individual in vitro assays for predicting a risk associated with substances acting through the same mode of action in water samples. Altogether, this study demonstrates the toxicological relevance of in vitro-based assessment of estrogenic activity and recommends the use of such in vitro/in vivo comparative approach to refine and validate EBTs for mechanism-based bioassays.
Introduction
During the last decades, numerous studies have reported the contamination of aquatic environments by endocrine disrupting chemicals (EDCs) resulting in adverse health effects on sensitive aquatic species including fish (Sumpter, 2005; Tyler et al., 1998) . Among EDCs, much attention has been paid to substances acting as agonists of the estrogen receptor (ER), notably natural and synthetic steroidal estrogens such as 17β-estradiol (E2), estrone (E1), and 17α-ethinyl estradiol (EE2), as they are widely released from waste water effluents into aquatic ecosystems at low but active concentrations on the reproductive fitness of aquatic species Kidd et al., 2007; Kidd et al., 2014; Nash et al., 2004) .
Monitoring of environmental estrogens has thus become of increasing relevance to assess the quality of water bodies . In that respect, the use of in vitro reporter gene assays to monitor estrogenic activity has proven relevant as they enable an integrative and quantitative assessment of ER-active contaminants in terms of 17βestradiol equivalents (EEQs), considering complex environmental mixtures of both, known and unknown, compounds (Mehinto et al., 2015; Snyder et al., 2001; Vethaak et al., 2005) . The high specificity and sensitivity of most established in vitro ER cell-based assays allow an EEQ quantification for a wide concentration range of water contamination with ER-agonists, including water with very low levels of estrogenic chemicals. Therefore, these types of bioassays are relevant for the monitoring of estrogenic activities in water bodies under different pressure levels (Kunz et al., 2015; Kunz et al., 2017) . However, the cellspecific transactivation of ER measured in vitro may not necessarily reflect the estrogenic activity observed in vivo in fish as many factors can influence the response of a given biological model such as interspecies differences for ER and toxicokinetics (adsorption, distribution, metabolization and excretion of chemical) resulting in differences between cell-based assay and responses in organisms (Le Fol et al., 2017; Van den Belt et al., 2004) . This has raised the question of the relevance of in vitro measurement of estrogenic activity to predict risk for aquatic species and ecosystems (Hotchkiss et al., 2008; Van den Belt et al., 2004) .
The determination of in vitro threshold values is an important element for the use of cell-based ER transactivation assays for the monitoring of the estrogenic potential in surface waters in order to discriminate between good and poor quality of water bodies. Effect-based trigger values (EBT) can be used as such threshold values. Different methodologies based on either environmental quality standards (EQS) of priority estrogenic chemicals Kunz et al., 2015; van der Oost et al., 2017) or measured values in environmental waters (Jarosova et al., 2014) have been proposed to derive EBT values for in vitro estrogenic activity, all proposed EBT values falling in the low ng/L range, i.e., an EEQ ranging from 0.1 to 1 ng E2/L Jarosova et al., 2014; Kase et al., 2018; Kunz et al., 2017; van der Oost et al., 2017) . However, a harmonization of EBT for in vitro effect-based methods is still missing . Furthermore, although the methodologies to derive EBT values based on PNEC (predicted no-effect concentration) or EQS consider in vivo responses in aquatic organisms, the links between in vitro estrogenic activity and in vivo effects in fish to define EBTs have been less investigated experimentally. Notwithstanding, qualitative and quantitative linkage between human or fish cell-based ER transactivation assays with estrogenic effect in aquatic organisms have been addressed previously using model estrogenic compounds and/or environmental samples (Cavallin et al., 2014; Henneberg et al., 2014; Ihara et al., 2015; Mehinto et al., 2018; Sonavane et al., 2016; Sonavane et al., 2018; Van den Belt et al., 2004) . To some extent, these studies showed the relevance of using in vitro assays to predict endocrine disruption in exposed-fish. Good correlations were found between in vitro ER transactivation and estrogenic responses in medaka but no specific EBT was derived from this study (Ihara et al., 2015) . In some studies, the absence of in vivo estrogenic responses for samples with low estrogenicity in vitro was correctly predicted (Mehinto et al., 2018) while in others estrogenic activity in fish was confirmed for the most active samples in vitro (Henneberg et al., 2014; Sonavane et al., 2016) . However, these studies were based on a limited number of active samples encompassing a broad range of estrogenic activity in vivo precluding a quantitative and robust assessment of the thresholds. Moreover, in vitro and in vivo comparison often relies on single cell-based assay without considering the variability between in vitro models (Kunz et al., 2017) that are commonly used for screening estrogenic activity.
In this context, our main objectives were 1) to determine whether an estrogenic activity measured in vitro triggers as well an in vivo response in a biological fish model, and 2) to test -based on this in vitro/ in vivo comparison -whether there exists an in vitro threshold value with a predictive power for the occurrence of effects in vivo. For that purpose, the in vivo estrogenic activities of 16 surface water (SW) and 17 wastewater (WW) samples were analyzed on a small-scale whole-organism assay that uses transgenic zebrafish cyp19a1b-GFP (Green Fluorescent Protein) embryos Tong et al., 2009 ). The samples were collected across Europe and analyzed in the frame of a previous Science-Policy Interface/Chemical Monitoring of Emerging Pollutants project. These samples have been previously well-characterized for estrogenic activities using five in vitro effect-based methods (ERα-CALUX, MELN, ER-GeneBlazer hERα-Hela9903, pYES) and for estrogen hormones using three analytical methods based on LC-MS/MS for E1, E2 and EE2 Konemann et al., 2018) . Herein they were further analyzed for their in vivo estrogenic activity using the EASZY assay (Detection of Endocrine Active Substance, acting through estrogen receptors, using transgenic cyp19a1b-GFP Zebrafish em-brYos), which allows the sensitive detection and quantification of environmental estrogens at an early developmental stage (0 to 4 days post fertilization) by quantifying the induction of the ER-regulated cyp19a1b gene (Menuet et al., 2005) in the developing brain by means of in vivo fluorescence imaging . The EASZY assay has been shown to sensitively respond to a diversity of ER-active compounds that belong to different chemical classes Cano-Nicolau et al., 2016; Le Fol et al., 2017; Neale et al., 2017) and to be a useful in vivo tool for evaluating binary and multi-component mixtures Hinfray et al., 2016; Hinfray et al., 2018; Petersen et al., 2013) or complex environmental matrices (Fetter et al., 2014; Sonavane et al., 2016; Sonavane et al., 2018) . Before analyzing the thirty-three environmental samples, a first step was to quantify the in vivo estrogenic potency of steroidal hormones in the EASZY assay using E1, E2 and EE2 standards and to assess the ability of the assay to quantify EE2 in spiked-water samples.
Material and methods

Chemicals
17β-estradiol (E2), 17α-ethinylestradiol (EE2) and estrone (E1) were obtained from Sigma-Aldrich (St-Quentin Fallavier, France). Stock solutions of chemicals were prepared in dimethyl sulfoxide (DMSO, Sigma-Aldrich) and stored at −20°C. Fresh dilutions of test chemicals were prepared before each experiment.
Water samples
All extracts of surface water (SW) and waste water (WW) tested in the present study were identical to the ones tested in the previous in vitro study . A total number of 16 SW and 17 WW samples were collected at selected sampling sites located in seven European countries. The samples were extracted using solid phase extraction (SPE) yielding 1000-fold concentrated organic extracts . For performing the EASZY assay, 1 mL of each extract (equivalent to 1 L of native sample) was further concentrated and resuspended in 0.1 mL of dimethylsulfoxide (DMSO), which was further diluted 1000-fold in the exposure medium. This means that the highest relative enrichment factor (REF) tested was 10.
In addition, surface water samples collected from the Netherlands were spiked with EE2 at two concentrations, 0.6 ng/L and 6.0 ng/L, and analyzed in the EASZY assay to demonstrate the ability of the assay to quantify estrogenic activity of water samples. Ultrapure water (1 L) was run in parallel to spiked water samples and used as extraction blank. All the protocols used for spiked water preparation, field sampling, and waste and surface water samples extraction were previously detailed in Konemann et al. (2018) .
Zebrafish exposure to single steroidal estrogens and to environmental samples: the EASZY assay
Newly fertilized transgenic cyp19a1b-GFP zebrafish eggs (up to 4 h post-fertilization) were exposed to the test substance or the environmental samples for 96 h under semi-static conditions with a complete renewal of the medium every 24 h. According to the EU Directive 2010/ 63/EU on the protection of animals used for scientific purposes, the EASZY assay does not fall into the regulatory frameworks dealing with animal experimentation (Strahle et al., 2012) and is considered as an F. Brion, et al. Environment International 130 (2019) 104896 alternative method for animal experiments. Each experimental group consisted of 20 embryos exposed in a crystallizing dish covered by a glass lid. For single test chemicals, the total volume of water was 25 mL and the final test concentration of DMSO was 0.01% (V/V). For environmental samples, the volume of water was set to 10 mL and the organic extract was diluted 1000-fold meaning that the final test concentration of DMSO was 0.1% (V/V). No effect on either the development of zebrafish or the GFP signal was observed in both DMSO control groups (0.01% and 0.1% (V/V)) compared to the water control group.
Zebrafish embryos were exposed to serial dilutions of single steroidal estrogen or extracts of water samples, using a dilution factor of 3 between serial concentrations. Typically, the organic extracts were tested at six different relative enrichment factors (REF), i.e. 10, 3, 1, 0.3, 0.1 and 0.03. For each experiment, a concentration-response curve of the reference substance (E2) was run in parallel to allow the quantification of the estrogenic activity present in the sample as ng E2equivalent (EEQ) per liter. For water samples spiked with EE2, a concentration-response curve of EE2 was used to quantify the estrogenic activity as ng EE2-equivalent (EE2-EQ) per liter.
Embryos were kept in an incubator at 28°C. At the end of the exposure period, 4-day post fertilization (dpf) old zebrafish were processed for fluorescence measurement by in vivo imaging using widefield fluorescence microscopy according to Brion et al., 2012 . Living cyp19a1b-GFP embryos were observed in dorsal view and the head was photographed using a Zeiss AxioImager.Z1 fluorescence microscope equipped with a AxioCam Mrm camera (Zeiss Gmbh, Göttingen, Germany) using the X10 objective, with a 134 ms exposure time at maximal intensity. Photographs were analyzed using the Zen software. The fluorescence signal was quantified using a specific ImageJ (Rasband, 1997 (Rasband, -2018 macro developed for the EASZY assay. The Fluorescence image AnalysiS Tool (FAST) macro is freely available at https://imagej. net/FAST/. For each picture, the integrated density was measured. It corresponds to the sum of the gray-values of all pixels, above 290 defined as background value, within the region of interest.
Data analysis
2.4.1. Quantification of relative estrogenic potency (REP) of steroidal hormones and estrogenic activity of water samples (EEQ)
The statistical analysis was performed on fold-induction data relative to negative (solvent) control. A Kruskal-Wallis test was performed for the analysis of the variance first, followed by a Dunn's post-hoc test. If the response was significantly increased compared to the negative control, the sample was defined as an active sample. Statistical analyses were performed using GraphPad Prism 5.00 (GraphPad Software, San Diego California USA). Concentration-response curves were modelled using log-transformed data. The Regtox 7.0.6 Microsoft Excel TM macro (http://www.normalesup.org/~vindimian/fr_index.html) uses the Hill equation model and allows calculation of EC 50 -values. For a given chemical, the EC 50 was defined as the concentration inducing 50% of its maximal effect. Relative estrogenic potencies (REP) were determined as the ratio of the EC 50 -value for the reference compound E2 to the EC 50value of the test chemical. If a concentration-response relationship of a compound did not reach the upper plateau, the modeling was performed using fixed parameters for slope and maximum taken from the E2-reference curve.
For active environmental samples in the EASZY assay, the estrogenic activity is expressed as ng E2-equivalent (EEQ) per liter. The EEQ was calculated as the ratio of the EC 20 of E2 (in ng/L) to the EC 20 of a given sample, which was expressed as a relative enrichment factor (REF) that considers both the concentration factor during the water extraction step and the dilution factor applied to the extract when performing the bioassay. For water samples spiked with EE2, the same approach was performed to quantify the estrogenic activity with EE2 as reference substance and the data were expressed as ng EE2-EQ per liter.
Linear regression analysis and logistic regression
The linear regression between log EEQ in vivo and log EEQ in vitro was performed using GraphPad Prism 5.00 (GraphPad Software, San Diego California USA). A t-test of Pearson's correlation coefficient was performed to analyze the statistical significance of the correlation.
Logistic regression was used to investigate the relation between the in vitro EEQs and the activity of the samples after exposure of transgenic embryos zebrafish, coded as a categorical variable with only two possible outcomes, activity or inactivity. The active samples were defined as described previously. Logistic regression was performed using function glm in R 3.3.1 (Team, 2016) . The optimal cut-off with the maximal sensitivity (or true positive rate) and specificity (or true negative rate) was selected using package ROCR (Sing et al., 2005) .
Sensitivity and specificity analysis
The sensitivity and specificity for the various combinations of in vitro assays with in vivo responses were expressed in percent and calculated according to Eqs. (1) and (2) respectively 
with t n true negative, i.e. in vitro estrogenic activity below the EBT with no in vivo estrogenic response; t p true positive, i.e. in vitro estrogenic activity above the EBT with in vivo estrogenic response in vivo; f n false negative, i.e. in vitro estrogenic activity below the EBT but in vivo response and f p false positive, i.e. in vitro estrogenic activity above the EBT but no estrogenic response in vivo.
Similarly, a sensitivity and specificity analysis for the EASZY assay regarding known mixture risk quotient, based on three high end chemical analytical data sets , was performed with t n true negative, i.e. no risk indicated by chemical analysis and in vivo EASZY; t p true positive, i.e. risk indicated by chemical analysis and in vivo EASZY; f n false negative, i.e. risk indicated by chemical analysis but not by in vivo and f p false positive, i.e. no risk indicated by chemical analysis but by in vivo.
Results and discussion
EASZY sensitively quantifies the estrogenic activity of steroidal estrogens
Exposure of transgenic zebrafish to synthetic (EE2) and natural (E1, E2) steroidal estrogens led to a strong and significant induction of GFP fluorescence in the developing brain of zebrafish (Fig. S1 ). The EC 20 and EC 50 values (Table 1) derived from modeling full concentrationresponse curves of the GFP-signal ( Fig. S2 ) revealed pronounced differences between these substances in the EASZY assay: EE2 is by far the most active steroidal estrogen with an EC 50 in the sub-nM range (EC 50 = 0.007 nM).
This result confirms the high responsiveness of the cyp19a1b gene and the EASZY assay to synthetic estrogens such as EE2, hexestrol and diethylstilbestrol Vosges et al., 2010) . The responsiveness of the EASZY assay for EE2 is very similar to the one observed in several cell based ER transactivation assays based on the comparison (Cosnefroy et al., 2012; Gutendorf and Westendorf, 2001) . In comparison, the natural hormones E2 and E1 were less active in vivo on brain cyp19a1b gene expression than EE2. The responsiveness of the EASZY assay to E2 markedly differed from in vitro models as the EC 50 values derived from cell-based assays were 6-to 75-fold lower than in transgenic model (Table 2) . For E1, comparing EASZY and in vitro cell models revealed a higher sensitivity than ER-GenBLAzer and Hela-9903 while a lower sensitivity as compared to ERα-CALUX and MELN cell lines (Table 2) . Such differences between the estrogenic activity of the two natural steroidal hormones (E1, E2) and EE2 have been previously reported in vivo based either on a ER-responsive transgenic zebrafish model (Legler et al., 2002) , endogenous hepatic ER-regulated gene expression in different fish species (Caldwell et al., 2012; Thorpe et al., 2003; Van den Belt et al., 2004) (Table S2 ). Based on its REP, EE2 is about 100 times more potent than E2 in vivo in the EASZY assay which agrees with the relative estrogenic potencies reported in other fish studies using in vivo reporter gene assay or induction of testis-ova in juvenile medaka (Legler et al., 2002; Metcalfe et al., 2001) . However lower REPs for EE2 were reported based on vitellogenin induction, and varied from 12 to 30 depending on the fish species and the life stage of exposure (Caldwell et al., 2012) . The rationale behind a higher REP for EE2 based on cyp19a1b induction compared to vitellogenin may rely on the cellcontext (i.e. glial versus hepatic cell context). In glial cells, a positive auto-regulation loop for the cyp19a1b gene contributes to an enhanced gene response signal and thus an increased sensitivity to potent ER ligand such as EE2.
Marked differences were also noticed for E1. This compound is 10 to 100 times less active than E2 in in vitro assays (except for MELN and pYES that present a higher sensitivity for E1), while it is only 1.5 times less active compared to E2 in vivo on the induction of the brain aromatase (Table 2) . This lower REP for E1 agrees with the data reported in different fish species based on vitellogenin concentrations (Table S2) , while in other studies E2 and E1 were found to be equipotent (Legler et al., 2002; Metcalfe et al., 2001) .
Altogether, these data illustrate the high sensitivity of the EASZY assay to steroidal estrogens especially to EE2 and to some extent to E1 as compared to in vitro cell-based assays. Furthermore, the quantification of the estrogenic activity measured in the short-term embryonic EASZY assay agrees with the estrogenic response measured in fish after prolonged exposure to steroidal hormones notably for EE2 (Table S2) , albeit more sensitive responses were reported for E2 and E1 after chronic exposure of rainbow trout, an estrogen-sensitive fish species (Thorpe et al., 2003) . The in vivo data also highlighted marked differences of relative potencies between EE2 and the natural steroidal hormones, E2 and E1. The lower in vivo responsiveness of natural steroidal estrogens compared to EE2 is likely to be explained by a metabolization of E2 and E1 in vivo, that lacks or is less prominent in the respective in vitro assays. Also, the tissue distribution, bioaccumulation potential of steroidal estrogens in vivo are important factors which the in vitro assays do not account for. This finding underlines the relevance of assays based on whole-organisms for the assessment of estrogenicity in environmental samples.
EASZY accurately quantifies the estrogenic activity of surface water spiked with EE2
The performance of the EASZY assay was first evaluated by quantifying the estrogenic activity of water samples spiked with EE2 at 0.6 ng/L ("low") and 6.0 ng/L ("high") as nominal concentrations. No estrogenic activity was detected in the blank sample whereas the two spiked water samples were active in the EASZY assay (Fig. S3 ). The comparison of measured EE2 concentrations and the determined in vivo EE2-EQ showed a high agreement between these two methods (Table 3) demonstrating the analytical performance of the EASZY assay to quantify the estrogenic activity of water samples.
A similar analytical performance was reported for the cell-based assays with average recoveries of 112% and 93% in terms of in vitro EEQ compared to measured EE2 concentrations for the low and the high spike-levels in the water samples, respectively .
In vivo quantification of estrogenic activity of waste and surface waters using EASZY
Each SW or WW sample was evaluated for its capacity to induce GFP-expression in the transgenic cyp19a1b-GFP zebrafish embryos. The results showed that 18 out of 33 samples significantly induced GFP compared to the solvent control (Fig. 1) .
Waste water (WW) samples induced the GFP-expression more frequently and to a higher extent than surface water (SW) samples. Twelve out of 17 tested WW samples and 6 out of 16 SW samples were assessed estrogenic in the EASZY assay. (Figs. S4 and S5 ). For WW samples, marked GFP induction was measured with maximal induction signal similar or even higher than in positive control zebrafish exposed to E2 (Fig. S4 ). Furthermore, concentration-dependent inductions of GFP were often reported for lower REF as compared to SW samples. For the most active WW sample (# S23), the lowest REF leading to a significant Table 2 In vivo and in vitro EC 50 values expressed in nM (and ng/L), and relative estrogenic potency (REP) for the steroidal estrogens in the in vivo EASZY assay and in vitro cell-based assays. The REP for the different in vitro effect-based methods were from . The REP for E2 was set to 1 in each assay. For the pYES, no EC50 data were derived and only the limit of quantification for E1, E2 and EE2 were reported in Table S1 as well as REP. As a result, the in vivo EEQs derived from these concentration-response relationships covered a broad range of estrogenic activity from the less active (15.9 EEQ ng/L) to the most active sample (673 EEQ ng/ L) (Fig. 2) .
It is noteworthy that as compared to in vitro EEQs, the estrogenic activities quantified in vivo were higher. Such difference may be related to a lower EC50 of E2 in in vitro assays, which raises the question of the reference substance for estrogen-equivalent calculation. For instance, since the EC50 values of EE2 are similar in in vitro and in vivo assays, the use of EE2 as a reference substance would have led to quantitative data with comparable order of magnitude (i.e., from 0.1 ng/L to 10 ng/L). Nevertheless, this data show the ability of the EASZY assay to detect ERagonists in complex mixtures and to quantify EEQs, as previously reported for other environmental matrices and samples (Sonavane et al., 2016; Sonavane et al., 2018) . Complementary to in vitro ER transactivation assays, the responses observed with the EASZY assay inform on the capacity of environmental contaminants to induce the ER-signaling in the developing brain of fish. The findings demonstrate that environmental estrogenic contaminants can reach internal organs and in particular the brain to target radial glial cells and impact the expression of the brain aromatase that has been associated with altered neurogenesis and behavioral changes in zebrafish (Diotel et al., 2010; Kinch et al., 2015) .
Correlation between in vitro and in vivo estrogenic activity: determination of effect-based trigger (EBT) values for in vitro estrogenic activities
When comparing in vivo and in vitro estrogenic profiles, all analyzed samples were found to be active in vitro while only 54% were active in vivo (Fig. 2) . Nevertheless, correlation analysis between in vivo-and in vitro-derived EEQs revealed that in vivo and in vitro estrogenic activities were significantly correlated for all tested in vitro assays (Table 4 ). Fig. 3 shows the relationship between in vivo EEQs derived from EASZY and in vitro EEQs derived from the GeneBLAzer and MELN assays.
Correlation graphs between EEQs from EASZY and those derived from HeLa9903, pYes and ERα-CALUX assays can be found in Fig. S6 .
Based on this graphical representation, a cut-off value allowing a Fig. 1 . In vivo imaging of the brain of 4-dpf old live transgenic cyp19a1b-GFP zebrafish embryos exposed to waste water (WW) and surface water (SW) sample extracts that were all able to induce a significant response above control in the EASZY assay. Fluorescent signal (green color) reveals induced GFP expression in the developing brain. Dorsal views (anterior to the top) of the telencephalon (tel), preoptic area (poa), and the caudal hypothalamus (hyp). For each water samples, the concentration factor (CF) of tested extract is indicated. CTRL: solvent control, E2 = 17β-estradiol, # = sample number. Scale bar = 100 μM. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.) Brion, et al. Environment International 130 (2019) 104896 clear discrimination between non-estrogenic and estrogenic samples in vivo could be clearly defined in case of the ER-GeneBLAzer. A similar finding resulted from the comparison between in vitro EEQs measured by ERα-CALUX and the EASZY assay in vitro (Fig. S6 ). However, for the MELN, HeLa9903 and pYES assays, such a graphical determination of in vitro cut-off values discriminating inactive and active samples was less obvious using this data set although the existence of a threshold is strongly suggested (Fig. 3B and Fig. S6 ).
To determine an optimal cut-off value with highest discriminative power for each bioassay, the relationships between in vivo and in vitro EEQs were further analyzed using a logistic regression model (by coding EASZY data as either "inactive" or "active" as described above). The generation of sensitivity and specificity curves as a function of the cut-off value allowed defining discriminative cut-off values for each assay, i.e. a value for which both, the sensitivity and the specificity were maximal. An example of such analysis for the GeneBLAzer and MELN assays is presented in the Fig. 4 (see also the Fig. S7 for the other in vitro assays).
Based on the comparison of in vitro EEQs and in vivo estrogenic activities, experimentally derived cut-off values were determined and suggested as assay-specific EBT values. These assay-specific EBTs allowed to identify true active (sensitivity) and true negative (specificity) samples with high probabilities (Table 5 ).
It is noteworthy that the assay-specific EBTs values defined herein are all within the same range of previously published EBTs for in vitro estrogenic activity, ranging from 0.1 to 1.01 EEQ/L Kase et al., 2018; Kunz et al., 2017; Jarosova et al., 2014; van der Oost et al., 2017) , thereby reinforcing the relevance of these proposed approaches. Notwithstanding the slight differences noticed between all the proposed EBTs, the EBTs derived from the in vitro and in vivo comparison allowed to substantially increase the sensitivity and the specificity of the in vitro assays and thus reducing the risk of false negative and false positive assessments (Table S3 ).
Do the in vivo responses inform on the risks posed by environmental estrogens to aquatic ecosystems?
While it appears relevant to link the measured effect in in vitro effect-based methods with relevant in vivo responses to define EBTs values, the question of the relevance of the in vivo bioassay response with respect to the risk for aquatic ecosystems has to be discussed (Mehinto et al., 2018) . Based on E1, E2 and EE2 concentrations, a cumulative risk quotient (RQ) representing the combined risk for the mixture of the three steroidal estrogens was calculated in all SW and WW samples investigated ). An RQ > 1 indicated an unacceptable risk for aquatic species while RQ < 1 indicated an acceptable risk for aquatic species. Interestingly, a strong association was found between the calculated RQ and in vivo estrogenic responses (Fig. 5) .
Among the 15 inactive samples in vivo, 13 samples presented no risk (RQ < 1) and for 14 out of 18 active samples the risk was evaluated as being unacceptable (RQ > 1). This means that the in vivo response reliably informs on the risk of mixtures of steroidal estrogens for aquatic species with a high sensitivity (87.5%) and specificity (75.5%) (see Table S4 ).
There were, however, some exceptions as elevated risk based on chemical analyses were noticed for two samples for which no in vivo responses were measured (i.e. # 27 RQ = 2.27 and # 17 RQ = 3.49). Such differences between chemically determined risk and in vitro effectbased method had already been noticed as these two samples were characterized by low in vitro estrogenic activities in all the cell-based assays (with the exception of the pYES for sample 17 with an EEQ = 0.690 ng/L) . Therefore, the in vivo responses reported herein support the responses measured in vitro. The samples #17 and #27 showed elevated levels for EE2 but comparably low levels of the other two estrogenic compounds analyzed by LC/MS, i.e. E1 and E2 . The fact that the RQ is based on the suggested EQS-levels explains this finding. The EQS is defined to be protective for the whole aquatic ecosystem which means that at EQS-level effects in vivo should not occur. Since the used model organism may not be the most sensitive fish species and the hazardous concentration thresholds for 5% of species (HC5) of 70 pg/L EE2 determined by a Species Sensitivity Distribution (SSD) approach was modified by an assessment factor of 2, it may happen that a sample shows a RQ > 1 but is not assessed as estrogenic by an in vivo assay. However, in most samples this was not the case and risks indicated based on the chemical analysis were captured by means of the biological assay. On the other hand, few other samples (samples #5, #14, #19 and #21) induced estrogenic effects in the developing fish brain whereas the risk quotient was below the value of one (RQ < 1) indicating no risk based on the chemical analysis of the three steroids. In vitro, moderate to high estrogenic activities were quantified in most cellular assays for these samples thereby indicating elevated risks Konemann et al., 2018) that were further confirmed by the in vivo assay in the present study. Since the induction of the brain aromatase is not an adverse effect per se it is not justified to define a risk for the aquatic environment in complete analogy to the risk assessment based on EQSexceedance. However, the results clearly demonstrate that ER-agonists were present in these samples that were not captured by chemical analysis. It means that these compounds were bioavailable and that this or these compounds were distributed in the whole organism resulting in F. Brion, et al. Environment International 130 (2019) 104896 brain tissue concentrations that were sufficient to trigger a biological response on the molecular level in vivo. This finding underlines the strength of this kind of in vivo bioassay, namely, the integral and unbiased detection of bioactive compounds in the environment. Altogether, these findings illustrate the relevance of the measured in vivo estrogenic responses regarding a chemical analysis risk assessment and the ability of effect-based methods (in vitro and in vivo) to capture mixture effects of (known) steroidal estrogens but also of other (unknown) substances acting by the activation of the ER (Altenburger et al., 2018; Kunz et al., 2015; Neale et al., 2015) . Finally, the finding that in vivo responses inform on the risk for aquatic species further supports the relevance of the suggested in vitro EBT values derived from the in vitro / in vivo correlation for estrogenic activities in the present study. This increases the discriminating power when interpreting in vitro estrogenic activities to assess the quality of the water bodies thereby lowering the probability of false positive and false negative assessments (Table 6 and Table S5 ). Kase et al. (2018) . A strong association between RQ and in vivo estrogenic responses was found (Chi2 test, p = 0.0002).
F. Brion, et al. Environment International 130 (2019) 104896 It has to be pointed out that the suggested EBT-values have to be further validated with independent data sets but the proposed sensitivity and specificity analysis allows the assessment of EBT-values in a straightforward manner.
Conclusions and outlooks
This study reports the in vivo estrogenic activities of surface and waste water samples based on their capacities to induce the ER-regulated cyp19a1b gene expression in the developing brain of zebrafish, thereby demonstrating that environmental ER ligands were bioavailable, distributed within the organism to target radial glial cells and induce brain aromatase expression. While the short-and long-term adverse outcome of brain aromatase disruption needs to be further explored (Diotel et al., 2013; Kinch et al., 2015; Vosges et al., 2012; Vosges et al., 2010) , this early molecular event might indicate a negative impact of substances capable of affecting the ER-signaling pathway in an intact organism.
Interestingly, the in vivo estrogenic activities were correlated with in vitro responses and to EQS mixture risk assessment. A sensitivity and specificity analysis allowed us to determine in vitro cut-off values with high discriminative power for each in vitro assay that were suggested as assay-specific effect-based trigger values (EBTs) above which in vivo responses were observed. This result further adds toxicological relevance to in vitro effect-based methods as predictive tools for observed responses at the organism level. It is also remarkable that, based on such in vitro vs in vivo correlations, the suggested EBT values were close to existing EBT-proposals. The refinement of EBTs based on the in vitro and in vivo comparison improves the sensitivity and specificity of five in vitro assays for predicting the risks associated with substances acting through the same mode of action. Thanks to this approach is was possible to achieve a high specificity and sensitivity gain for EQS mixture effects and biological relevance of 5 different in vitro EBM in mean of > 95%. This further supports the relevance of in vitro tools as specific and reliable tools for an efficient environmental monitoring of substances acting as estrogens.
To our knowledge, no other mode of action of endocrine disrupting chemicals has so far been able to provide a level of information comparable with the one gained with the present study on 33 realistic samples of seven EU member states investigated with three high resolution HPLC MS/MS, five in vitro ER transactivation assays Konemann et al., 2018) and the in vivo EASZY assay (this study). Neverthless, it would be advisable to extend it to other case studies (e.g., WFD monitoring sites) to validate the proposed EBTs. Furthermore, the in vivo responses were measured on a specific zebrafish assay (having its own advantages and limits) hence questioning if similar EBTs would have defined using other fish models and endpoints of estrogenic activity. However, the data provided are sufficiently robust to illustrate a proof of concept to define or refine EBTs. Hence, similar experimental approaches can be recommended for other mode of action, notably those that are mediated through nuclear receptors.
Such approach would however require robust and reliable in vivo screening biological models which are currently lacking for most of NRmediated effects.
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